Status: Recruiting
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
This is a multicenter, open-label, phase I clinical study employing a dose-escalation and cohort-expansion design to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of CSCJC3456 in patients with advanced malignant solid tumors.
Participants needed: 102
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.Updated: Sep 21, 2026Locations: 2
Eligibility criteria
Voluntarily sign the informed consent form and follow protocol requirements; [+12]
Radically cured basal cell carcinoma of the skin, superficial bladder cancer, sq... [+23]